Literature DB >> 2066541

Can decision analysis help in the management of giant hemangioma of the liver?

D Gilon, P E Slater, J Benbassat.   

Abstract

We explore the trade-off between the risk and expected benefits from resection of giant liver hemangioma (GLH), one larger than 4 cm in diameter. We searched the English-language literature for studies of the postoperative mortality after resection of GLH and of the outcome of expectantly treated patients. The results of the data synthesis showed an operative mortality of 1.5% (90% confidence intervals, 0.1-3.0%) and an early surgical morbidity of up to 13%. Mortality among the 37 reported cases with ruptured GLH was 78%. There were no cases of spontaneous or traumatic rupture of unresected GLH during a follow-up of a total of 282 patient years. The main source of ambiguity regarding the management of GLH is the uncertain risk of its rupture. Rough estimates of this risk based on published data suggest that surgical resection is not justified in asymptomatic GLH. Yet, although rare, rupture of GLH does occur with disastrous consequences. Future research may attempt to define patient subsets whose GLHs are at higher risk of rupture, and in whom preventive resection may improve survival.

Entities:  

Mesh:

Year:  1991        PMID: 2066541

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  CT and MRI findings correlate with the time-course of unresectable cavernous haemangioma of the liver after fractionated radiotherapy.

Authors:  H-L Lee; T-S Chung; S-W Chen; W T Lao
Journal:  Br J Radiol       Date:  2012-03       Impact factor: 3.039

2.  Differential diagnoses and diagnostic troubleshooting of upper abdominal masses.

Authors:  Danielle A Bischof; Michael A Choti
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-06

Review 3.  Benign solid tumors of the liver: management in the modern era.

Authors:  Georgios Antonios Margonis; Aslam Ejaz; Gaya Spolverato; Neda Rastegar; Robert Anders; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2015-01-06       Impact factor: 3.452

Review 4.  Postoperative severe microangiopathic hemolytic anemia associated with a giant hepatic cavernous hemangioma.

Authors:  Kaysie L Banton; Jonathan D'Cunha; Noel Laudi; Catherine Flynn; Dale Hammerschmidt; Abhinav Humar; Timothy Sielaff
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

5.  Resection of giant liver hemangioma in a pregnant woman with coagulopathy: Case report and literature review.

Authors:  Yasuhiko Ebina; Ryoichi Hazama; Masashi Nishimoto; Kenji Tanimura; Yoshiya Miyahara; Mayumi Morizane; Koji Nakabayashi; Takumi Fukumoto; Yonson Ku; Hideto Yamada
Journal:  J Prenat Med       Date:  2011-10

6.  Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis.

Authors:  T Takahashi; S Kuwao; H Katagiri; A Kakita
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

7.  Laparoscopic versus open surgery in the treatment of hepatic hemangioma: A meta-analysis.

Authors:  He Jien; Li Xiaohua
Journal:  Medicine (Baltimore)       Date:  2021-02-26       Impact factor: 1.817

8.  A case of spontaneously ruptured hepatic angiosarcoma resected after transcatheter arterial embolization.

Authors:  Toshiaki Kashiwadate; Yasuyuki Hara; Eiji Hashizume; Akiko Nishida; Michiaki Unno; Takashi Kamei
Journal:  J Surg Case Rep       Date:  2022-09-27

9.  Indications for liver surgery in benign tumours.

Authors:  Margot Fodor; Florian Primavesi; Eva Braunwarth; Benno Cardini; Thomas Resch; Reto Bale; Daniel Putzer; Benjamin Henninger; Rupert Oberhuber; Manuel Maglione; Christian Margreiter; Stefan Schneeberger; Dietmar Öfner; Stefan Stättner
Journal:  Eur Surg       Date:  2018-05-22       Impact factor: 0.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.